Multi-layer spatial profiling reveals early response- associated immune remodeling after one cycle of neoadjuvant combination therapy in triple-negative breast cancer
Year: 2026
Type: preprint
Abstract: Background Early identification of response to neoadjuvant therapy remains challenging in triple-negative breast cancer (TNBC), and conventional cell-density measurements may not fully capture treatment-induced changes in the spatial organisation of the tumour immune microenvironment. We investigated whether early spatial remodelling after a single treatment cycle was associated with subsequent pathological response. Methods This retrospective translational analysis used prospectively collected matched pre-treatment and post-cycle-1 core-needle biopsies from ten TNBC patients (five pCR and five non-pCR) enrolled in a clinical trial of neoadjuvant sintilimab, anlotinib and sequential chemotherapy. Six-colour multiplex immunofluorescence (CD8, CD20, CD68, FOXP3, PANCK and DAPI) was applied, and more than 1.7 million single cells were evaluated using a four-tier spatial framework comprising immune-cell density, tumour–immune spatial co-localisation, immune hotspot organisation and within-hotspot cellular interactions. Results After one treatment cycle, intratumoral and stromal CD8 + T-cell densities increased, whereas intratumoral CD68 + macrophages and stromal FOXP3 + regulatory T cells decreased. Tumour–CD20 + B-cell spatial co-localisation increased at the raw P-value level but did not survive FDR correction. The intratumoral immune hotspot score (Sintra/immune) decreased predominantly in patients who subsequently achieved pCR, and post-treatment values differed between pCR and non-pCR groups at the raw P-value level (P = 0.032; q = 0.064; exploratory ROC AUC = 0.92, 95% CI 0.66–1.00). Within immune hotspots, intratumoral CD68+–FOXP3 + interactions decreased and CD20+–CD8 + interactions increased across the cohort (both q < 0.05). Peritumoral CD20+–FOXP3 + interaction changes also differed between response groups (P = 0.032), although this association did not survive FDR correction. Conclusions These findings identify rapid spatial reorganisation of the TNBC immune microenvironment after a single treatment cycle and exploratory hotspot-level features associated with subsequent pathological response. Larger prospective cohorts are required for validation.
Source: Research Square
Authors: Jiao-mei Yuan, Fei Ji, Kun Wang
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7236046401
